Evidence for Contributions of Interactions of Constituents to the Anti-Inflammatory Activity of Hypericum Perforatum

Critical Reviews in Food Science and Nutrition

Volumn 54, Issue 6, 2014, Pages 781-789

  Hammer, Kimberly D P ^a   Birt, Diane F ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

amentoflavone; bioactive constituents; chlorogenic acid; Hypericum perforatum; inflammation; interactions; pseudohypericin; quercetin

Indexed keywords

AMENTOFLAVONE; BIOACTIVE CONSTITUENTS; CHLOROGENIC ACIDS; HYPERICUM PERFORATUM; INFLAMMATION; PSEUDOHYPERICIN; QUERCETIN;

BEAM PLASMA INTERACTIONS; BIOCHEMISTRY; FLAVONOIDS;

PHENOLS;

AMENTOFLAVONE; ANTIINFLAMMATORY AGENT; BIFLAVONOID; DRUG DERIVATIVE; FLAVONOID; HYPERFORIN; PERYLENE; PHLOROGLUCINOL; PLANT EXTRACT; PSEUDOHYPERICIN; TERPENE;

ANIMAL; CHEMISTRY; DISEASE MODEL; HUMAN; HYPERICUM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIFLAVONOIDS; DISEASE MODELS, ANIMAL; FLAVONOIDS; HUMANS; HYPERICUM; PERYLENE; PHLOROGLUCINOL; PLANT EXTRACTS; SIGNAL TRANSDUCTION; TERPENES;

EID: 84890672763     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2011.607519     Document Type: Review

References (54)

1. Abdel-Salam, O. M. E. 2005. Anti-inflammatory, anti-nociceptive, and gastric effects of Hypericum perforatum in rats. Scientific World Journal, 5: 585 - 595.
2. Agostinis, P., Vantieghem, A., Merlevede, W. and de Witte, P. A. M. 2002. Hypericin in cancer treatment: More light on the way. Int. J. Biochem. Cell Biol., 34: 221 - 241.
3. Albert, D., Zundorf, I., Dingermann, T. and Muller, W. E. 2002. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem. Pharmacol., 64: 1767 - 1775.
4. Alcaraz, M. J. and Hoult, J. R. S. 1985. Actions of flavonoids and the novel anti-inflammatory flavone, hypolaetin-8-glucoside, on prostaglandin biosynthesis and inactivation. Biochem. Pharmacol., 34: 2477 - 2482.
5. Assefa, Z., Vantieghem, A., Declercq, W., Vandenabeele, P., Vandenheede, J. R., Merlevede, W., de Witte, P. and Agostinis, P. 2002. The activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J. Biol. Chem., 274 (13): 8788 - 8796.
6. Azuma, K., Ippoushi, K., Nakayama, M., Ito, H., Higashio, H. and Terao, J. 2000. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J. Agric. Food Chem., 48: 5496 - 5500.
7. Biber, A., Fischer, H., Romer, A. and Chatterjee, S. S. 1998. Oral bioavailability of hyperforin from Hypericum extracts in rats and human volunteers. Pharmacopsychiatry., 1: 36 - 43.
8. Bilia, A. R., Gallori, S. and Vincieri, F. F. 2002. St. John's wort and depression: Efficacy, safety and tolerability-an update. Life Sci., 70: 3077 - 3096.
9. Blank, M., Lavie, G., Mandel, M., Hazan, S., Orenstein, S., Meruelo, D. and Keisari, Y. 2004. Antimetastatic activity of the photodynamic agent hypericin in the dark. Int. J. Cancer., 111: 596 - 603.
10. Bork, P. M., Bacher, S., Schmitz, M. L., Kaspers, U. and Heinrich, M. 1999. Hypericin as a non-antioxidant inhibitor of NF-κB. Planta Med., 65: 297 - 300.
11. 2 and hyperoside: A pharmacokinetic study in rats. Planta Med., 69: 189 - 192.
12. Carpenter, S. and Kraus, G. A. 1991. Photosensitization is required for inactivation of equine infectious anemia virus by hypericin. Photochem. Photobiol., 53 (2): 167 - 174.
13. Cervo, L., Rozio, M., Ekalle-Soppo, C. B., Guiso, G., Morazzoni, P. and Caccia, S. 2002. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology, 164 (4): 423 - 428.
14. Chi, Y. S., Jong, H., Son, K. H., Chang, H. W., Kang, S. S. and Kim, H. P. 2001. Effects of naturally occurring prenylated flavonoids on arachidonic acid metabolizing enzymes: Cyclooxygenases and lipoxygenases. Biochem. Pharmacol., 62: 1185 - 1191.
15. Cho, S.-Y., Park, S.-J., Kwon, M.-J., Jeong, T.-S., Bok, S.-H., Choi, W.-Y., Jeong, W.-I., Ryu, S.-Y., Do, S.-H., Lee, C.-S., Song, J.-C. and Jeong, K.-S. 2003. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-κB pathway in lipopolysaccharide-stimulated macrophage. Mol. Cell Biochem., 243: 153 - 160.
16. 2 pathways by a 4 component system mimicking an Hypericum perforatum fraction. Phytochemistry., 69: 2354 - 2362.
17. Hammer, K. D. P., Hillwig, M. L., Solco, A. K. S., Dixon, P. M., Delate, K., Murphy, P. A., Wurtele, E. S. and Birt, D. F. 2007. Inhibition of prostaglandin E2 production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW264.7 mouse macrophage cells. J. Ag Food Chem., 55: 7325 - 7331.
18. Hammer, K. D. P., Yum, M.-Y., Dixon, P. M. and Birt, D. F. 2010. Identification of pathways important for the anti-inflammatory activity of an Hypericum perforatum fraction and four putative bioactive constituents in RAW 264.7 mouse macrophages using microarray analysis. Phytochemistry., 71: 716 - 725.
19. Herold, A., Cremer, L., Calugaru, A., Tamas, V., Ionescu, F., Manea, S. and Szegli, G. 2003. Hydroalchoholic plant extracts with anti-inflammatory activity. Roum. Arch. Microbiol. Immunol., 62 (1-2): 117 - 129.
20. Hendrickx, N., Volanti, C., Moens, U., Seternes, O. M., de Witte, P., Vandenheede, J. R., Piette, J. and Agostinis, P. 2003. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J. Biol. Chem., 278 (52): 52231 - 52239.
21. Huang, N., Rizshsky, L., Hauck, C., Nikolau, B. J., Murphy, P. A. and Birt, D. F. 2011. Identification of anti-inflammatory constituents in Hypericum perforatum and Hypericum gentianoides extracts using RAW 264.7 mouse macrophages. Phytochemistry, 16: 2015 - 2023.
22. Huang, N., Rizshsky, L., Hauck, C., Nikolau, B. J., Murphy, P. A. and Birt, D. F. 2012. The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in Hypericum perforatum extract is partially dependent on the activation of SOCS3. 76: 106 - 116. Phytochemistry
23. Kerb, R., Brockmoller, J., Staffeldt, B., Ploch, M. and Roots, I. 1996. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicr. Agents Chem., 40: 2087 - 2093.
24. 2. Prostaglandins Leukot. Essent. Fatty Acids., 65: 281 - 286.
25. Kumar, V., Singh, P. N. and Bhattacharya, S. K. 2001. Anti-inflammatory and analgesic activity of Indian Hypericum perforatum L. Indian J. Exp. Biol., 39 (4): 339 - 343.
26. 2 by p-bromophenyclacyl bromide, nordihydroguaiaretic acid, 5,8,11,13-eicosatetrayenoic acid and quercetin. Int. Archs. Allergy Appl. Immun., 76: 214 - 217.
27. Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W. and Melchart, D. 1996. St. John's wort for depression: An overview and meta-analysis of randomised clinical trials. BMJ., 313: 253 - 258.
28. Manjeet, R. K. and Ghosh, B. 1999. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-α production in murine macrophages. Int. J. Immunopharmacol., 21: 435 - 443.
29. Martarelli, D., Martarelli, B., Pediconi, D., Nabissi, M. I., Perfumi, M. and Pompei, P. 2004. Hypericum perforatum methanolic extract inhibits growth of human prostatic carcinoma cell line orthotopically implanted in nude mice. Cancer Lett., 210: 27 - 33.
30. Menegazzi, M., Di Paola, R., Mazzon, E., Muia, C., Genovese, T., Crisafulli, C., Suzuki, H. and Cuzzocrea, S. 2006. Hypericum perforatum attenuates the development of carrageenan-induced lung injury in mice. Free Radic. Biol. Med., 40: 740 - 753.
31. Miller, A. L. 1998. St. John's wort (Hypericum perforatum): Clinical effects on depression and other conditions. Altern. Med. Rev., 3 (1): 18 - 26.
32. Morikawa, K., Nonaka, M., Narahara, M., Torii, I., Kawaguchi, K., Yoshikawa, T., Kumazawa, Y. and Morikawa, S. 2003. Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci., 74: 709 - 721.
33. Murota, K., Shimizu, S., Chujo, H., Moon, J.-H. and Terao, J. 2000. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Biochem. Biophys., 384: 391 - 397.
34. Nair, M. P., Mahajan, S., Reynolds, J. L., Aalinkeel, R., Nair, H., Schwartz, S. A. and Kandaswami, C. 2006. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-κB system. Clin. Vaccine Immunol, 13 (3): 319 - 328.
35. Noldner, M. and Schotz, K. 2002. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med., 68: 577 - 580.
36. Raso, G. M., Pacilio, M., Di Carlo, G., Esposito, E., Pinto, L. and Meli, R. 2002. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J. Pharm. Pharmacol., 54: 1379 - 1383.
37. Rossi, A., Ligresti, A., Longo, R., Russo, A., Borrelli, F. and Sautebin, L. 2002. The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages. Phytomedicine, 9 (6): 530 - 535.
38. Schempp, C. M., Hezel, S. and Simon, J. C. 2003. Topical treatment of atopic dermatitis with Hypericum cream. A randomised, placebo-controlled, double-blind half-side comparison study. Hautarzt., 54 (3): 245 - 253.
39. Schulz, H. U., Schurer, M., Bassler, D. and Weiser, D. 2005. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin, and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a Hypericum extract containing tablet. Arzneimittelforschung., 55 (1): 15 - 22.
40. Schmitt, L. A., Liu, Y., Murphy, P. A. and Birt, D. F. 2006. Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds. J. Ag. Food Chem., 54: 2881 - 2890.
41. Schmitt, L. A., Liu, Y., Murphy, P. A., Petrich, J. W., Dixon, P. M. and Birt, D. F. 2006. Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds. J. Photochem. Photobiol. B., 85 (2): 118 - 130.
42. 2 production. Eur. J. Pharmacol, 44: 187 - 194.
43. Shipochliev, T., Dimitrov, A. and Aleksandrova, E. 1981. Anti-inflammatory action of a group of plant extracts. Vet. Med. Nauki., 18 (6): 87 - 94.
44. Sosa, S., Pace, R., Bornaracin, A., Morazonni, P., Riva, A., Tubaro, A. and Della Loggia, R. 2007. Topical anti-inflammatory activity of extract and compounds from Hypericum perforatum L. J Pharm. Pharmacol, 59 (5): 703 - 709.
45. Stalkos, D., Gioti, E., Stalikas, C. D., Meyer, H., Papazoglou, T. G. and Filippidis, G. 2006. Photophysical properties of Hypericum perforatum L. extracts-Novel photosensitizers for PDT. J. Photochem. Photobiol. B., 82: 146 - 151.
46. Staffeldt, B., Kerb, B., Brockmoller, J., Ploch, M. and Roots, I. 1991. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract LI 160 in healthy volunteers. J. Geriatr. Psychiatry Neurol.,: S47 - S53.
47. Taher, M. M., Lammering, G. M., Hershey, C. M. and Valerie, K. C. 2002. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light. IUBMB Life, 54 (6): 357 - 364.
48. Tedeschi, E., Menegazzi, M., Margotto, D., Suzuki, H., Forstermann, U. and Kleinert, H. 2003. Anti-inflammatory actions of St. John's wort: Inhbition of human inducible nitric-oxide synthase expression by down regulating signal transducer and activator of transcription-1α (STAT-1α) activation. J. Pharmacol. Exp. Therap., 307 (1): 254 - 261.
49. Wadsworth, T. L., McDonald, T. L. and Koop, D. R. 2001. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide- induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem. Pharmacol., 62: 963 - 974.
50. Wang, L., Tu, Y.-C., Lian, T.-W., Hung, J.-T., Yen, J.-H. and Wu, M.-J. 2006. Distinctive antioxidant and antiinflammatory effects of flavonols. J. Agric. Food Chem., 54: 9789 - 9804.
51. Wilhelm, K. P., Biel, S. and Siegers, C. P. 2001. Role of flavonoids in controlling the phototoxicity of Hypericum perforatum extracts. Phytomedicine, 8 (4): 306 - 309.
52. Williamson, E. M. 2001. Synergy and other interactions of phytomedicines. Phytomedicine., 8 (5): 401 - 409.
53. Woo, E. R., Lee, J. Y., Cho, I. J., Kim, S. G. and Kang, K. W. 2005. Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-κB activation in macrophages. Pharmacol. Res., 51: 539 - 546.
54. Zhou, C., Tabb, M. M., Sadatrafiei, A., Grun, F., Sun, A. and Blumberg, B. 2004. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-κB-independent pathway. J. Clin. Immunol., 24 (6): 623 - 636.